Logo image of OWLT

OWLET INC (OWLT) Stock Fundamental Analysis

USA - NYSE:OWLT - US69120X2062 - Common Stock

8.17 USD
-0.01 (-0.12%)
Last: 9/19/2025, 8:04:01 PM
8.17 USD
0 (0%)
After Hours: 9/19/2025, 8:04:01 PM
Fundamental Rating

2

Taking everything into account, OWLT scores 2 out of 10 in our fundamental rating. OWLT was compared to 191 industry peers in the Health Care Equipment & Supplies industry. OWLT has a bad profitability rating. Also its financial health evaluation is rather negative. OWLT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OWLT had negative earnings in the past year.
OWLT had a negative operating cash flow in the past year.
OWLT had negative earnings in each of the past 5 years.
In the past 5 years OWLT always reported negative operating cash flow.
OWLT Yearly Net Income VS EBIT VS OCF VS FCFOWLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

OWLT has a Return On Assets of -81.71%. This is in the lower half of the industry: OWLT underperforms 75.39% of its industry peers.
Industry RankSector Rank
ROA -81.71%
ROE N/A
ROIC N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OWLT Yearly ROA, ROE, ROICOWLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

OWLT has a Gross Margin (52.59%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of OWLT has grown nicely.
The Profit Margin and Operating Margin are not available for OWLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
OWLT Yearly Profit, Operating, Gross MarginsOWLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

OWLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OWLT has more shares outstanding
OWLT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OWLT has an improved debt to assets ratio.
OWLT Yearly Shares OutstandingOWLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
OWLT Yearly Total Debt VS Total AssetsOWLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

OWLT has an Altman-Z score of -5.19. This is a bad value and indicates that OWLT is not financially healthy and even has some risk of bankruptcy.
OWLT has a worse Altman-Z score (-5.19) than 69.63% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.19
ROIC/WACCN/A
WACC10.07%
OWLT Yearly LT Debt VS Equity VS FCFOWLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

2.3 Liquidity

A Current Ratio of 1.15 indicates that OWLT should not have too much problems paying its short term obligations.
OWLT's Current ratio of 1.15 is on the low side compared to the rest of the industry. OWLT is outperformed by 83.77% of its industry peers.
A Quick Ratio of 0.93 indicates that OWLT may have some problems paying its short term obligations.
OWLT has a worse Quick ratio (0.93) than 79.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.93
OWLT Yearly Current Assets VS Current LiabilitesOWLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

OWLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.78%, which is quite impressive.
OWLT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.68%.
Measured over the past years, OWLT shows a quite strong growth in Revenue. The Revenue has been growing by 9.40% on average per year.
EPS 1Y (TTM)86.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3029.76%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%26.09%

3.2 Future

Based on estimates for the next years, OWLT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.12% on average per year.
The Revenue is expected to grow by 28.04% on average over the next years. This is a very strong growth
EPS Next Y-86.21%
EPS Next 2Y5.94%
EPS Next 3Y26.98%
EPS Next 5Y29.12%
Revenue Next Year32.11%
Revenue Next 2Y27.38%
Revenue Next 3Y24.75%
Revenue Next 5Y28.04%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OWLT Yearly Revenue VS EstimatesOWLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
OWLT Yearly EPS VS EstimatesOWLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OWLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OWLT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OWLT Price Earnings VS Forward Price EarningsOWLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OWLT Per share dataOWLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as OWLT's earnings are expected to grow with 26.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.94%
EPS Next 3Y26.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OWLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OWLET INC

NYSE:OWLT (9/19/2025, 8:04:01 PM)

After market: 8.17 0 (0%)

8.17

-0.01 (-0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners50.55%
Inst Owner Change10.12%
Ins Owners6.03%
Ins Owner Change-0.12%
Market Cap139.54M
Analysts81.82
Price Target13.46 (64.75%)
Short Float %2.92%
Short Ratio5.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)76.31%
Min EPS beat(2)74.89%
Max EPS beat(2)77.72%
EPS beat(4)4
Avg EPS beat(4)87.88%
Min EPS beat(4)74.89%
Max EPS beat(4)112.26%
EPS beat(8)5
Avg EPS beat(8)-0.79%
EPS beat(12)7
Avg EPS beat(12)-3.26%
EPS beat(16)8
Avg EPS beat(16)-9.43%
Revenue beat(2)2
Avg Revenue beat(2)14.75%
Min Revenue beat(2)14.05%
Max Revenue beat(2)15.44%
Revenue beat(4)3
Avg Revenue beat(4)10.86%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)17.47%
Revenue beat(8)4
Avg Revenue beat(8)-0.84%
Revenue beat(12)4
Avg Revenue beat(12)-2.56%
Revenue beat(16)5
Avg Revenue beat(16)-10.84%
PT rev (1m)13.55%
PT rev (3m)27.74%
EPS NQ rev (1m)11.27%
EPS NQ rev (3m)-57.5%
EPS NY rev (1m)-8.03%
EPS NY rev (3m)-23.3%
Revenue NQ rev (1m)4.23%
Revenue NQ rev (3m)10.72%
Revenue NY rev (1m)5.74%
Revenue NY rev (3m)7.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS5.26
BVpS-2.6
TBVpS-2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.59%
FCFM N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
F-Score3
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.34%
Cap/Sales 0.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 0.93
Altman-Z -5.19
F-Score3
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)56.11%
Cap/Depr(5y)93.79%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3029.76%
EPS Next Y-86.21%
EPS Next 2Y5.94%
EPS Next 3Y26.98%
EPS Next 5Y29.12%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%26.09%
Revenue Next Year32.11%
Revenue Next 2Y27.38%
Revenue Next 3Y24.75%
Revenue Next 5Y28.04%
EBIT growth 1Y33.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year106.5%
EBIT Next 3Y41.73%
EBIT Next 5Y31.23%
FCF growth 1Y68.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.09%
OCF growth 3YN/A
OCF growth 5YN/A